Position in BNTX
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$15,213,234
-$7,270,626 QoQ
Shares Held
171,166
-27.5% QoQ
Ownership
0.068%
of shares outstanding
% of Portfolio
0.82%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CenterBook Partners LP holds $104,676,185 across 36 Biotechnology names. BNTX ranks #1 (14.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BNTX |
BioNTech SE
This page
|
171,166 | $15,213,234 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
150,912 | $11,331,982 | |
| 3 | ARGX |
Argenx SE
|
13,934 | $10,175,303 | |
| 4 | RPRX |
Royalty Pharma plc
|
157,177 | $7,539,780 | |
| 5 | INSM |
INSMED Inc
|
35,232 | $5,761,136 | |
| 6 | TVTX |
Travere Therapeutics, Inc.
|
157,122 | $4,668,094 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,060 | $3,909,558 | |
| 8 | VERA |
Vera Therapeutics, Inc.
|
97,003 | $3,902,430 |
All Filings in BNTX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $15,213,234 | 171,166 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $22,483,860 | 236,175 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $18,293,122 | 185,491 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $22,991,557 | 215,944 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $9,963,512 | 109,417 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $22,119,746 | 194,118 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $14,188,501 | 119,462 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $16,572,964 | 206,234 | Shares | Sole | 2024-08-12 | |
| No filing history on record for this holder in this stock. | ||||||